NASDAQ · PG
Consumer Defensive · Household & Personal Products
$144.08
Up+$0.17 (+0.12%)
Updated Aug 13, 2026, 6:35 PM
SID Score
6.9/10
Composite research score
Smart Money
56/100
Neutral
Price performance
1M range · 21 trading sessions · Daily adjusted prices
PG closed at $144.08 after 21 trading sessions, down 2.68% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 12, 2026 | $144.05 | $144.94 | $143.79 | $144.08 | 7.2M |
| Aug 11, 2026 | $145.41 | $145.71 | $143.93 | $145.21 | 7.94M |
| Aug 10, 2026 | $144.73 | $146.46 | $144.15 | $146.44 | 7.39M |
| Aug 7, 2026 | $144.90 | $146.00 | $143.88 | $145.79 | 7.57M |
| Aug 6, 2026 | $147.82 | $148.50 | $145.45 | $146.97 | 8.77M |
| Aug 5, 2026 | $147.845 | $147.845 | $144.66 | $146.80 | 9.75M |
| Aug 4, 2026 | $144.04 | $148.25 | $143.79 | $148.01 | 7.36M |
| Aug 3, 2026 | $145.85 | $147.15 | $144.26 | $144.97 | 8.94M |
| Jul 31, 2026 | $143.51 | $144.70 | $141.46 | $144.49 | 9.15M |
| Jul 30, 2026 | $143.76 | $144.45 | $142.25 | $143.96 | 9.57M |
| Jul 29, 2026 | $141.38 | $146.38 | $140.20 | $146.10 | 14.62M |
| Jul 28, 2026 | $151.50 | $153.68 | $148.52 | $148.88 | 12.85M |
| Jul 27, 2026 | $147.85 | $150.245 | $147.85 | $148.63 | 7.3M |
| Jul 24, 2026 | $146.45 | $147.99 | $145.40 | $147.41 | 6.62M |
| Jul 23, 2026 | $146.14 | $147.61 | $145.59 | $146.97 | 6.5M |
| Jul 22, 2026 | $149.50 | $150.46 | $148.815 | $149.13 | 5.37M |
| Jul 21, 2026 | $147.86 | $148.41 | $146.88 | $148.10 | 7.03M |
| Jul 20, 2026 | $149.56 | $150.10 | $148.43 | $149.13 | 5.79M |
| Jul 17, 2026 | $152.86 | $154.32 | $149.31 | $149.98 | 8.92M |
| Jul 16, 2026 | $149.49 | $151.52 | $148.175 | $151.50 | 6.49M |
| Jul 15, 2026 | $145.28 | $148.59 | $144.66 | $148.05 | 6.18M |
The latest Smart Investors Daily articles mentioning PG.
PG research
Company profile and research snapshot.
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of nearly $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 7, 2026 | Argus Research | Hold | — |
| Jul 30, 2026 | Citigroup | Buy | — |
| Jul 30, 2026 | HSBC | Hold | — |
| Jul 21, 2026 | Barclays | Equal-Weight | — |
| Jul 16, 2026 | JP Morgan | Overweight | — |
No generated briefing is available yet.
Yahoo · Aug 13, 2026
Procter & Gamble isn't a flashy company, but its dividend will appeal to investors looking for a payout they can count on.
Yahoo · Aug 12, 2026
These stocks have terrific track records for dividend growth, and they're likely to continue raising their payouts for the foreseeable future.
SeekingAlpha · Aug 12, 2026
Kimberly-Clark looks good, supported by a strong innovation pipeline, international growth, and the Kenvue acquisition. See why I rate KMB stock a Buy.
Yahoo · Aug 11, 2026
Procter & Gamble (PG) has just updated investors with full year 2027 guidance, new quarterly earnings expectations, and fresh details on capital returns, including dividends and share buybacks, all released alongside its latest annual results. See our latest analysis for Procter & Gamble. At a share price of $146.44, Procter & Gamble has seen a 3.28% year to date share price return, while the 1 year total shareholder return is down 2.73%. This signals momentum that is still relatively muted...
Interpretive context generated from the platform’s current data sources.
Procter & Gamble shares traded at $144.09, reflecting a modest daily gain of 0.09% but broader weakness across multiple timeframes. Per SID market data, PG declined 2.13% over the trailing one-month period and posted a 1.2% loss over the past year, underperforming the broader market. On a three-month basis, the stock managed a slight 1.29% gain. Technically, PG trades below both key moving averages, sitting under its 50-day moving average of $147.61 and its 200-day moving average of $149.59, indicating sustained downward pressure. The 14-day relative strength index registers at 38.8, approaching oversold territory below the conventional 30 threshold. According to Massive/Polygon data, average daily trading volume stands at approximately 8.54 million shares. The stock's beta of 0.382 confirms its historically low volatility relative to the broader market, consistent with its Consumer Defensive sector classification and its $328.9 billion market capitalization.
Procter & Gamble currently trades at a price-to-earnings ratio of 20.46, per SID market data, which positions the stock at a moderate premium relative to broader market averages but within historical norms for large-cap consumer staples companies. The PEG ratio stands at 3.90, suggesting the stock is priced at a significant premium relative to its expected earnings growth rate, a metric that warrants attention from growth-oriented investors. According to SEC filings, PG carries a price-to-book ratio of 6.44, reflecting the substantial intangible asset base and brand portfolio characteristic of the company's business model. The dividend yield of 2.97% remains a notable component of total shareholder return and positions PG among the higher-yielding names in the Consumer Defensive sector. These valuation metrics collectively indicate a stock priced for stability and income generation rather than aggressive capital appreciation at current levels.
The Procter & Gamble Company registers a composite smart money score of 56 out of 100, signaling a neutral overall positioning among sophisticated market participants, per SID market data. Institutional ownership strength scores a perfect 25 out of 25, reflecting robust conviction from large fund managers and consistent with PG's status as a widely held blue-chip defensive name. Notably, according to SEC Form 4 filings, all six insider transactions recorded over the past 90 days were purchases, with zero insider sales during the period, earning an insider activity score of 12.5 out of 25. This unanimously bullish insider buying pattern suggests company executives see value at current price levels. Dark pool activity scored 9.0 out of 25, indicating below-average off-exchange institutional accumulation. Congressional trading activity registered at 9.6 out of 25, per 13F institutional filings, showing limited legislative interest. The divergence between strong institutional ownership and moderate insider scores creates a mixed but cautiously constructive smart money profile for PG shareholders.
Procter & Gamble has demonstrated a consistent pattern of exceeding analyst expectations in its most recent reported quarters. According to company earnings reports, the fiscal quarter reported on July 29, 2026, delivered earnings per share of $1.43 against a consensus estimate of $1.42, representing a $0.01 positive surprise. The prior quarter reported on April 24, 2026, showed a stronger beat, with actual EPS of $1.59 versus the $1.56 estimate, a $0.03 upside surprise. Looking ahead, analyst estimates project EPS of $1.42 for the upcoming quarter scheduled for July 28, 2026, and $1.57 for the quarter expected on April 23, 2026. The relatively narrow magnitude of recent earnings surprises reflects the predictability of PG's mature consumer staples business model. The sequential decline from $1.59 to $1.43 in reported EPS aligns with typical seasonal patterns in Procter & Gamble's fiscal reporting cycle.
Recent Wall Street analyst activity for Procter & Gamble reveals a moderating sentiment trend. Per SID consensus data, Argus Research downgraded PG from Buy to Hold on August 7, 2026, the most recent rating change on record. Similarly, HSBC downgraded its rating from Buy to Hold on July 30, 2026, contributing to a pattern of two downgrades within a single week. Counterbalancing these moves, Citigroup maintained its Buy rating on July 30, 2026, while JP Morgan reiterated its Overweight stance on July 16, 2026, according to Wall Street analyst reports. Barclays maintained its Equal-Weight rating on July 21, 2026. The current distribution shows two firms at Buy or Overweight, one at Equal-Weight, and two at Hold, reflecting a consensus that leans neutral. The clustering of downgrades in late July and early August 2026 coincides with post-earnings reassessments, suggesting analysts are recalibrating growth expectations following the most recent quarterly results.
The latest Smart Investors Daily articles mentioning PG.
